Molecular Characterization and Putative Pathogenic Pathways of Tuberous Sclerosis Complex-Associated Renal Cell Carcinoma.
Park JH, Lee C, Chang MS, Kim K, Choi S, Lee H, Lee HS, Moon KC.
Park JH, et al.
Transl Oncol. 2018 Aug;11(4):962-970. doi: 10.1016/j.tranon.2018.05.010. Epub 2018 Jun 18.
Transl Oncol. 2018.
PMID: 29925043
Free PMC article.
The mTOR pathway activation and the germline mutations of TSC2 were identified in both TSC-RCC cases. The WES revealed several cancer gene alterations. In Case 1, genetic alterations of CHD8, CRISPLD1, EPB41L4A, GNA11, NOTCH3, PBRM1, PTPRU, RGS12, SETBP1, SMARCA4, S …
The mTOR pathway activation and the germline mutations of TSC2 were identified in both TSC-RCC cases. The WES revealed several cancer …